Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Assets (2016 - 2026)

OptimizeRx's Assets history spans 16 years, with the latest figure at $176.9 million for Q4 2025.

  • On a quarterly basis, Assets rose 3.36% to $176.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $176.9 million, a 3.36% increase, with the full-year FY2025 number at $176.9 million, up 3.36% from a year prior.
  • Assets hit $176.9 million in Q4 2025 for OptimizeRx, up from $170.3 million in the prior quarter.
  • Over the last five years, Assets for OPRX hit a ceiling of $183.4 million in Q4 2023 and a floor of $121.3 million in Q2 2023.
  • Historically, Assets has averaged $151.1 million across 5 years, with a median of $144.2 million in 2021.
  • Biggest five-year swings in Assets: surged 144.17% in 2021 and later dropped 17.72% in 2023.
  • Tracing OPRX's Assets over 5 years: stood at $141.0 million in 2021, then fell by 4.49% to $134.7 million in 2022, then surged by 36.18% to $183.4 million in 2023, then dropped by 6.66% to $171.2 million in 2024, then rose by 3.36% to $176.9 million in 2025.
  • Business Quant data shows Assets for OPRX at $176.9 million in Q4 2025, $170.3 million in Q3 2025, and $169.3 million in Q2 2025.